Orgenesis Inc (ORGS)

Orgenesis Inc. is a biotechnology company focused on cell and gene therapies in the United States. The company operates through two segments, Octomera and Therapies, and is developing its Point of Care (POCare) platform around licensed cell-based therapies produced with closed, automated technology systems. Its collaborative POCare model relies on a network of research institutes and hospitals. Orgenesis also works on autologous and cell-based immunotherapies, as well as treatments targeting metabolic diseases, viral diseases, and tissue regeneration. In addition to its therapy development activities, the company provides hospital services and cell process development services. Founded in 2008, it was previously known as Business Outsourcing Service, Inc. and adopted the Orgenesis name in August 2011. The company is headquartered in Germantown, Maryland, and its common stock trades on OTC Markets under the symbol ORGS.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.